Sirnaomics Ltd. (HKG:2257)
7.17
+0.27 (3.91%)
At close: Feb 13, 2026
Sirnaomics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 1.78 | 1.78 | - | - | - | - |
Other Revenue | -0.83 | - | - | 0.71 | 0.07 | - |
| 0.95 | 1.78 | - | 0.71 | 0.07 | - | |
Revenue Growth (YoY) | 39.35% | - | - | 892.96% | - | - |
Cost of Revenue | 0.58 | 0.58 | - | - | - | - |
Gross Profit | 0.37 | 1.2 | - | 0.71 | 0.07 | - |
Selling, General & Admin | 9.55 | 17.16 | 23.16 | 24.19 | 16.12 | 5.16 |
Research & Development | 9.6 | 20.8 | 54.38 | 67.64 | 40.67 | 14.89 |
Other Operating Expenses | -0.97 | -0.97 | -0.46 | - | - | -0.21 |
Operating Expenses | 18.18 | 36.99 | 77.09 | 91.83 | 56.79 | 19.85 |
Operating Income | -17.81 | -35.79 | -77.09 | -91.13 | -56.72 | -19.85 |
Interest Expense | -0.91 | -1.05 | -0.99 | -0.8 | -0.34 | -0.24 |
Interest & Investment Income | 0.03 | 0.06 | 0.96 | 1.35 | 0.21 | 0.08 |
Currency Exchange Gain (Loss) | 0 | 0.01 | -0 | -0.3 | -0.56 | -0.14 |
Other Non Operating Income (Expenses) | 10.01 | 6.89 | -1.68 | -6.52 | -158.84 | -19.72 |
EBT Excluding Unusual Items | -8.68 | -29.89 | -78.8 | -97.39 | -216.25 | -39.87 |
Gain (Loss) on Sale of Investments | -0.07 | -18.18 | 0.26 | 0.05 | 0.31 | 0.39 |
Gain (Loss) on Sale of Assets | 0.05 | -0.03 | -0.18 | -0.04 | 0 | - |
Asset Writedown | -2.19 | -2.19 | -8.35 | - | - | 0.24 |
Other Unusual Items | 0.75 | 0.04 | 2.07 | - | - | -7.19 |
Pretax Income | -10.14 | -50.25 | -84.99 | -97.38 | -215.93 | -46.43 |
Earnings From Continuing Operations | -10.14 | -50.25 | -84.99 | -97.38 | -215.93 | -46.43 |
Minority Interest in Earnings | -3.88 | -1.14 | 6.3 | 9.08 | 2.86 | 2.66 |
Net Income | -14.02 | -51.38 | -78.69 | -88.3 | -213.07 | -43.77 |
Net Income to Common | -14.02 | -51.38 | -78.69 | -88.3 | -213.07 | -43.77 |
Shares Outstanding (Basic) | 86 | 77 | 76 | 76 | 15 | 14 |
Shares Outstanding (Diluted) | 86 | 77 | 76 | 76 | 15 | 14 |
Shares Change (YoY) | 13.67% | 1.86% | 0.06% | 410.22% | 7.91% | 12.50% |
EPS (Basic) | -0.16 | -0.66 | -1.03 | -1.16 | -14.30 | -3.17 |
EPS (Diluted) | -0.16 | -0.66 | -1.03 | -1.16 | -14.30 | -3.17 |
Free Cash Flow | -9.37 | -19.84 | -72.03 | -107.54 | -62.05 | -21.09 |
Free Cash Flow Per Share | -0.11 | -0.26 | -0.95 | -1.42 | -4.17 | -1.53 |
Gross Margin | 38.99% | 67.44% | - | 100.00% | 100.00% | - |
Operating Margin | -1876.40% | -2012.99% | - | -12925.82% | -79890.14% | - |
Profit Margin | -1476.92% | -2889.93% | - | -12524.68% | -300100.00% | - |
Free Cash Flow Margin | -986.93% | -1115.64% | - | -15253.62% | -87397.18% | - |
EBITDA | -15.48 | -31.12 | -72.3 | -89.02 | -55.87 | -19.27 |
D&A For EBITDA | 2.32 | 4.67 | 4.78 | 2.11 | 0.86 | 0.58 |
EBIT | -17.81 | -35.79 | -77.09 | -91.13 | -56.72 | -19.85 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.